免疫检测点抑制剂及其生物标志物在晚期实体肿瘤中的研究进展(4)
[5] Philips GK， Atkins M. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies. Int Immunol， 2015， 27(1)：39-46.[6] Ngiow SF， Teng MW， Smyth MJ. Prospects for TIM3-targeted antitumor immunotherapy. Cancer Res， 2011， 71(21)：6567-6571.
[7] Woo SR， Turnis ME， Goldberg MV， et al. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Res ......
您现在查看是摘要页，全文长 2721 字符。